CONCORDDRUGSLTD logo

Concord Drugs Ltd

CONCORDDRUGSLTD·NSE·
0.00 +0.00 (+0.00%)
Market Cap100.78 Cr
PE Ratio51.10
Volume
Day High - Low
52W High-Low92.52 - 56.17
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
1.9/10
Poor
Fair Value
Sign in to see
ROE
2.52%
Weak
P/E
51.10x
Expensive
Debt / Equity
0.24
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

52W56.17
92.52
DocStoX take

Held back by valuation (0.0). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
1.9
/10
Poor
Quality
Weak
ROE 2.5%
Valuation
Expensive
P/E 51.1×
Growth
Flat
Revenue +8.9% 5Y CAGR
Risk
Elevated
D/E 0.24
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹101 Cr
52W High / Low
₹93 / ₹56
Dividend Yield
0.00%
Promoter Holding
45.08%
EPS (TTM)
₹0.30
Book Value
₹36.82

Key highlights

  • Low leverage — D/E 0.24
  • Profitable in all of the last 5 years
  • Profit shrinking 20% a year
  • Quality is weak (2.2/10)
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Concord Drugs Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Concord Drugs Ltd (CONCORDDRUGSLTD) Share Price | DocStoX